SCHEMBL6702230

SCHEMBL6702230

Cc1cnc(C)c(OCc2ccccc2)c1C(O)P(=O)(O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ PTPN1 P18031 1/20 0.39
▸ ALPG P10696 1/20 0.39
▸ PTK2B Q14289 1/20 0.39
▸ P4HTM Q9NXG6 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ GLRA1 P23415 1/20 0.36
▸ PTGER1 P34995 1/20 0.36
▸ PTGER4 P35408 1/20 0.36
▸ PTGER3 P43115 1/20 0.36
▸ PTGER2 P43116 1/20 0.36
▸ PDPK1 O15530 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5666900 0.85 LMNA (0.36) LMNAHPGDALDH1A1TSHRHTT
SCHEMBL10247058 0.74 PTPN1 (0.47) LMNAHPGDTSHRHTTMAPK1
SCHEMBL10247270 0.73 PTPN1 (0.49) LMNAHPGDALDH1A1TSHRHTT
SCHEMBL5665055 0.72 POLB (0.49) LMNAPTPN1POLBGAAGLRA1
SCHEMBL5665433 0.72 L3MBTL1 (0.42) LMNAHPGDTSHRHTTMAPK1
SCHEMBL5665324 0.70 L3MBTL1 (0.43) LMNAHPGDALDH1A1HTTMAPK1
SCHEMBL5666549 0.70 PNPO (0.38) LMNAHPGDALDH1A1KDM4EMEN1
SCHEMBL6280878 0.68 PTPN1 (0.40) LMNAHPGDALDH1A1TSHRMAPK1
SCHEMBL82592 0.66 THRB (0.43) LMNAHPGDALDH1A1HTTMAPK1
SCHEMBL5664859 0.66 L3MBTL1 (0.44) LMNAHPGDALDH1A1HTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040186077-A1 Novel heteroaryl phosphonates as cardioprotective agents MEDICURE INTERNATIONAL INC. (BB) 2004-09-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186077-A1 Novel heteroaryl phosphonates as cardioprotective agents TNNT2, TNNI3, ADRB3 LMNA 1102/4885HPGD 836/4885ALDH1A1 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback